Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Total Current Liabilities (2020 - 2023)

Historic Total Current Liabilities for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $23.4 million.

  • Cullinan Therapeutics' Total Current Liabilities fell 1354.5% to $23.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $23.4 million, marking a year-over-year decrease of 1354.5%. This contributed to the annual value of $22.5 million for FY2022, which is 9153.75% up from last year.
  • According to the latest figures from Q3 2023, Cullinan Therapeutics' Total Current Liabilities is $23.4 million, which was down 1354.5% from $19.7 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Total Current Liabilities ranged from a high of $62.0 million in Q2 2022 and a low of $5.7 million during Q2 2021
  • For the 4-year period, Cullinan Therapeutics' Total Current Liabilities averaged around $20.6 million, with its median value being $18.5 million (2022).
  • In the last 5 years, Cullinan Therapeutics' Total Current Liabilities soared by 98018.46% in 2022 and then tumbled by 6828.24% in 2023.
  • Cullinan Therapeutics' Total Current Liabilities (Quarter) stood at $14.3 million in 2020, then decreased by 17.97% to $11.7 million in 2021, then soared by 91.54% to $22.5 million in 2022, then increased by 4.2% to $23.4 million in 2023.
  • Its Total Current Liabilities was $23.4 million in Q3 2023, compared to $19.7 million in Q2 2023 and $26.2 million in Q1 2023.